Alessandro Graziani

Alessandro Graziani

Auto-generated profile, based on publicly available information

Alessandro Graziani

Medicina Interna Sub Intensiva, Ospedale Santa Maria Delle Croci, Viale Randi 3, 48121 Ravenna Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
MCMario Casmiro
Mario Casmiro
AGAlessandro Graziani
Alessandro Graziani

24 August 2020 in Pulmonology
Verified
Journal Article
Open access
AGA. Graziani
A. Graziani
MDM. Domenicali
M. Domenicali
GZG. Zanframundo
G. Zanframundo
FPF. Palmese
F. Palmese
BCB. Caroli
B. Caroli
LGL. Graziani
L. Graziani

5 August 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
FPFrancesco Palmese
Francesco Palmese
BCBarbara Caroli
Barbara Caroli
AGAlessandro Graziani
Alessandro Graziani
GZGrazia Zanframundo
Grazia Zanframundo
RTRossella Del Toro
Rossella Del Toro
MDMarco Domenicali
Marco Domenicali
Daily Evaluation of COVID-19 Patients Primarily Based on Lung Ultrasound: In Times of Emergency, It's Time to Change Some Paradigms

21 June 2021 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
GZGrazia Zanframundo
Grazia Zanframundo
AGAlessandro Graziani
Alessandro Graziani
BCBarbara Caroli
Barbara Caroli
FPFrancesco Palmese
Francesco Palmese
CBCristian Bertoldi
Cristian Bertoldi
MDMarco Domenicali
Marco Domenicali
Novel Coronavirus disease (COVID-19) has been widely described as the cause for a proinflammatory and hypercoagulable state. The inflammatory process involving the alveolar vascular endothelium in the respiratory system, is a determining factor for the onset of primary Pulmonary Artery Thrombosis (PAT) even in patients with heparin prophylactic treatment. Little is known about the efficacy of the anticoagulant therapy during the course of PAT caused by COVID-19. In this paper we describe the results obtained in patients with moderate COVID-19 disease, previously threated with prophylactic enoxaparin, who then received full Anticoagulant treatment after diagnosis of PAT. After three months Computed Tomography Pulmonary Angiography demonstrated a complete resolution of the vascular obstructive lesions in all patients, while all the coagulation tests were normal.

22 September 2022 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
AGAlessandro Graziani
Alessandro Graziani
CSCaterina Savrie
Caterina Savrie
MSMaria Giulia Sama
Maria Giulia Sama

28 February 2022 in Polish Heart Journal
Verified
Journal Article
Closed access
PDF file
AGAlessandro Graziani
Alessandro Graziani
PCPatrizia Cenni
Patrizia Cenni
MLMatteo Lisi
Matteo Lisi
MDMarco Domenicali
Marco Domenicali
LGLudovico Graziani
Ludovico Graziani